Immunotherapy (APC8015, Provenge) targeting prostatic acid phosphatase can induce durable remission of metastatic androgen-independent prostate cancer: a Phase 2 trial.

Patrick A Burch; Gary A Croghan; Dennis A Gastineau; Lori A Jones; Judith S Kaur; Jelle W Kylstra; Ronald L Richardson; Frank H Valone; Stanimir Vuk-Pavlović

doi:10.1002/pros.20040

Immunotherapy (APC8015, Provenge) targeting prostatic acid phosphatase can induce durable remission of metastatic androgen-independent prostate cancer: a Phase 2 trial.

Identifier:nobleid.org/w1/20260515/BC0FD819

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/BC0FD819.svg?ark=w1%2F20260515%2FBC0FD819)](https://nobleid.org/work/w1/20260515/BC0FD819)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Stanimir Vuk-Pavlović

Claim authorship of this work

Immunotherapy (APC8015, Provenge) targeting prostatic acid phosphatase can induce durable remission of metastatic androgen-independent prostate cancer: a Phase 2 trial.

Identifier:nobleid.org/w1/20260515/BC0FD819

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/BC0FD819.svg?ark=w1%2F20260515%2FBC0FD819)](https://nobleid.org/work/w1/20260515/BC0FD819)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Stanimir Vuk-Pavlović

Claim authorship of this work